ouabain has been researched along with 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynch, JJ; Rahwan, RG | 1 |
| Weishaar, RE | 1 |
2 other study(ies) available for ouabain and 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene
| Article | Year |
|---|---|
Absence of blocking effects on cardiac slow calcium channels by the intracellular calcium antagonist 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart; In Vitro Techniques; Indenes; Ion Channels; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain | 1982 |
"Calcium antagonists" and "calcium agonists": is there a place in pharmacology for these two misnomers?
Topics: Animals; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Indenes; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardium; Ouabain; Theophylline | 1984 |